0001520138-23-000269.txt : 20230626
0001520138-23-000269.hdr.sgml : 20230626
20230626160600
ACCESSION NUMBER: 0001520138-23-000269
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230621
FILED AS OF DATE: 20230626
DATE AS OF CHANGE: 20230626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DO CUONG V
CENTRAL INDEX KEY: 0001477037
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39015
FILM NUMBER: 231042395
MAIL ADDRESS:
STREET 1: C/O BIOVIE
STREET 2: 2120 COLORADO AVENUE, SUITE 230
CITY: SANTA MONICA
STATE: CA
ZIP: 90404
FORMER NAME:
FORMER CONFORMED NAME: Do Cuong V
DATE OF NAME CHANGE: 20091118
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOVIE INC.
CENTRAL INDEX KEY: 0001580149
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462510769
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
BUSINESS PHONE: 775-888-3162
MAIL ADDRESS:
STREET 1: 680 W NYE LANE
STREET 2: SUITE 201
CITY: CARSON CITY
STATE: NV
ZIP: 89703
FORMER COMPANY:
FORMER CONFORMED NAME: NANOANTIBIOTICS, INC.
DATE OF NAME CHANGE: 20130625
4
1
ownership.xml
X0407
4
2023-06-21
0
0001580149
BIOVIE INC.
BIVI
0001477037
DO CUONG V
C/O BIOVIE INC.
680 W NYE LANE STE 201
CARSON CITY
NV
89703
1
1
0
0
CEO & President
0
Common Stock
2023-06-21
4
M
0
41506
A
271401
I
See Footnote
Restricted stock units
2023-06-21
4
M
0
41506
0
D
Common Stock
41506
83014
I
See Footnote
Granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan.
Securities are held in the name of Do & Rickles Investments LLC.
Each restricted stock unit represents a contingent right to receive one share of the issuer's Class A common stock.
The restricted stock units were granted on June 21, 2022 and vest ratably over a three-year period on each anniversary of the grant date.
/s/ Cuong V Do
2023-06-21